Form 6-K NOVO NORDISK A S For: Nov 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Mikael Dolsten withdraws board candidacy at Novo Nordisk
November 14, 2025 6:19 AM ESTMikael Dolsten has withdrawn his candidacy for Novo Nordisk's (NYSE: NVO) Board of Directors due to personal circumstances, the Danish pharmaceutical company announced.
Dolsten, who previously served as Head of Research and Development at Pfizer, informed Novo Nordisk that he would not seek election... More



